Publication:

Novel Expression and Characterization of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1) by Conjunctival Cells

Loading...
Thumbnail Image

Date

2005

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

Association for Research in Vision and Ophthalmology (ARVO)
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Chen, Lu, Claus Cursiefen, Stefano Barabino, Qiang Zhang, and M. Reza Dana. 2005. “Novel Expression and Characterization of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1) by Conjunctival Cells.” Investigative Opthalmology & Visual Science 46 (12) (December 1): 4536. doi:10.1167/iovs.05-0975.

Abstract

Purpose. Lymphatic vessel endothelial hyaluronic acid receptor (LYVE-1) is a newly discovered lymphatic-specific marker. To date, there is no report of its expression on conjunctival cells. The purpose of this study was to investigate the expression of LYVE-1 in normal conjunctiva, to phenotype LYVE-1+ cells, and to study changes in their expression levels during corneal inflammation.

Methods. Flatmounted conjunctivae or cross sections of eyeballs were harvested from BALB/c mice (6–8 weeks of age) for immunofluorescent confocal microscopic studies.

Results. The data demonstrate, for the first time, that in addition to its expression on lymphatic vessels, LYVE-1 was expressed on CD45+, CD11b+, and CD31− conjunctival cells, indicating a bone-marrow–derived monocytic lineage. Surprisingly, the number of cells that expressed LYVE-1 decreased during corneal inflammation, in conjunction with ingrowth of lymphatics into the cornea.

Conclusions. A new population of monocytic cells has been found to express LYVE-1 in normal conjunctiva. These cells that normally express LYVE-1 may act as a reservoir for lymphangiogenesis and cell recruitment when the immune system is challenged.

Description

Other Available Sources

Research Data

Keywords

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories